Glucokinase Activator-based Systems for Industrial, Agricultural, and Biotechnological Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of glucokinase activators to develop novel systems and methods for optimizing energy efficiency, enhancing crop yields, detecting kidney damage, treating muscle cramps, and improving microbial fuel cells.
Background and Problem Solved
The original patent focuses on treating diabetes with renal impairment using glucokinase activators. However, the potential of glucokinase activators extends beyond this specific application. This inventive concept addresses the limitation of the original patent by exploring new use cases in industries such as energy production, agriculture, biotechnology, and sports medicine.
Detailed Description of the Inventive Concept
The inventive concept comprises systems and methods that utilize glucokinase activators to achieve specific benefits in various industries. For instance, in industrial processes, glucokinase activators can optimize energy efficiency and reduce emissions. In agriculture, these activators can enhance crop yields in drought-prone regions by improving water use efficiency. In biotechnology, glucokinase activators can detect and prevent kidney damage in athletes, while in sports medicine, they can treat and prevent exercise-induced muscle cramps. Additionally, glucokinase activators can optimize energy production in microbial fuel cells.
Novelty and Inventive Step
The novelty of this inventive concept lies in the application of glucokinase activators to entirely new industries and use cases, which were not originally considered in the original patent. The inventive step is the recognition of the potential of glucokinase activators to address specific problems in these industries and the development of systems and methods to achieve these benefits.
Alternative Embodiments and Variations
Alternative embodiments of this inventive concept could include the use of different glucokinase activators, such as GKA-1, GKA-2, and GKA-3, or the development of new activators with improved properties. Variations could also include the integration of glucokinase activators with other technologies, such as IoT sensors or machine learning algorithms, to enhance their effectiveness.
Potential Commercial Applications and Market
The commercial potential of this inventive concept is significant, with potential applications in industries such as energy production, agriculture, biotechnology, and sports medicine. The target market includes companies and organizations operating in these industries, as well as research institutions and government agencies.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology with emphasis on metabolic disorder treatment, specifically glucokinase activation and renal impairment management
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced degrees in biochemistry or pharmacology, understanding enzyme modulation, metabolic pathways, and therapeutic applications of enzyme activators
Obviousness Rationale
A PHOSITA would recognize that the source patent's fundamental disclosure of glucokinase activators for treating metabolic disorders provides a clear technological foundation for exploring diverse applications. The PTD's variations represent predictable extensions of the core technology by applying known enzymatic mechanisms to solve problems in different domains. The systematic approach of adapting glucokinase activators across industrial, agricultural, and biotechnological contexts demonstrates the inherent versatility of the original therapeutic concept.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,536 |
|---|---|
| Title | Glucokinase activator for treating diabetes with renal impairment |
| Assignee(s) | HUA Medicine (Shanghai) Ltd. |